Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : CMGI What is the latest news on this stock? -- Ignore unavailable to you. Want to Upgrade?

To: Todd Pagel who wrote (8349)	5/17/1999 10:45:00 PM
From: James Thompson	Respond to of 19700

Todd, Chemdex filing. Good hunting, Jim Chemdex Corporation 3950 Fabian Way Palo Alto, CA 94303 Phone: 650-813-0300 Fax: 650-813-0304 Web Site: chemdex.com IPO INFORMATION Filing date: May 14, 1999 Expected IPO date: TBA Exchange: Nasdaq Proposed ticker: CMDX Offering amount (mil.): $86.3 Underwriters: Morgan Stanley Dean Witter; BancBoston Robertson Stephens; Volpe Brown Whelan & Company KEY NUMBERS Fiscal Year-End: December 1998 Sales (mil.): $0.0 1998 Income (mil.): $(8.5) Employees: 87 KEY PEOPLE CEO: David P. Perry CFO: James G. Stewart Chemdex Corporation offers an online catalog of life science research equipment and materials. The company's Chemdex Marketplace features about 240,000 products from some 100 suppliers, allowing procurers to purchase all necessary equipment from a single source; products include reagents, specialty chemicals, and research equipment. The company is planning to expand its catalog to 550,000 products, partly through a deal with laboratory supply distributor VWR Scientific Products. Chemdex markets its products to commercial and academic research programs of entities such as Genentech, Harvard University, Elan, and the University of Illinois. Genentech accounts for more than 80% of revenues.